T G Johns - JoVE Visualize

Showing results (11-20 of 29) with videos related to

Pageof 3

Sort By:

Oncogene|April 22, 2014

Glioma-specific Domain IV EGFR cysteine mutations promote ligand-induced covalent receptor dimerization and display enhanced sensitivity to dacomitinib in vivoS A Greenall, J F Donoghue, N G Gottardo, et al.

Journal of Molecular Medicine (Berlin, Germany)|February 1, 1997

Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosisC C Bernard, T G Johns, A Slavin, et al.

Biochemistry International|July 1, 1992

Validation of the MTT dye assay for enumeration of cells in proliferative and antiproliferative assaysB E Loveland, T G Johns, I R Mackay, et al.

Journal of the National Cancer Institute|August 5, 1992

Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon betaT G Johns, I R Mackay, K A Callister, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1995

Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosisT G Johns, N Kerlero de Rosbo, K K Menon, et al.

Human Reproduction (Oxford, England)|May 10, 2014

Combination gefitinib and methotrexate treatment for non-tubal ectopic pregnancies: a case seriesA W Horne, M M Skubisz, S Tong, et al.

Cell Death Discovery|August 24, 2016

Cytotoxic activity of the MK2 inhibitor CMPD1 in glioblastoma cells is independent of MK2Fms Gurgis, M C Åkerfeldt, B Heng, et al.

Cell Death and Differentiation|September 3, 2013

The regulation of mitochondrial DNA copy number in glioblastoma cellsA Dickinson, K Y Yeung, J Donoghue, et al.

Biochemistry and Molecular Biology International|August 1, 1993

Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studiesS Abo, C C Bernard, M Webb, et al.

Oncogene|February 10, 2015

EGFRvIII-mediated transactivation of receptor tyrosine kinases in glioma: mechanism and therapeutic implicationsS A Greenall, J F Donoghue, M Van Sinderen, et al.

Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:

Pageof 3

Oncogene|April 22, 2014

Glioma-specific Domain IV EGFR cysteine mutations promote ligand-induced covalent receptor dimerization and display enhanced sensitivity to dacomitinib in vivoS A Greenall, J F Donoghue, N G Gottardo, et al.

Journal of Molecular Medicine (Berlin, Germany)|February 1, 1997

Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosisC C Bernard, T G Johns, A Slavin, et al.

Biochemistry International|July 1, 1992

Validation of the MTT dye assay for enumeration of cells in proliferative and antiproliferative assaysB E Loveland, T G Johns, I R Mackay, et al.

Journal of the National Cancer Institute|August 5, 1992

Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon betaT G Johns, I R Mackay, K A Callister, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1995

Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosisT G Johns, N Kerlero de Rosbo, K K Menon, et al.

Human Reproduction (Oxford, England)|May 10, 2014

Combination gefitinib and methotrexate treatment for non-tubal ectopic pregnancies: a case seriesA W Horne, M M Skubisz, S Tong, et al.

Cell Death Discovery|August 24, 2016

Cytotoxic activity of the MK2 inhibitor CMPD1 in glioblastoma cells is independent of MK2Fms Gurgis, M C Åkerfeldt, B Heng, et al.

Cell Death and Differentiation|September 3, 2013

The regulation of mitochondrial DNA copy number in glioblastoma cellsA Dickinson, K Y Yeung, J Donoghue, et al.

Biochemistry and Molecular Biology International|August 1, 1993

Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studiesS Abo, C C Bernard, M Webb, et al.

Oncogene|February 10, 2015

EGFRvIII-mediated transactivation of receptor tyrosine kinases in glioma: mechanism and therapeutic implicationsS A Greenall, J F Donoghue, M Van Sinderen, et al.

Pageof 3